IQE plc
("IQE" or the "Company")
Directors' Dealings and total voting rights
06 May 2011
IQE announces that to facilitate the planned closure of an employee benefit
trust that was established in 2001 as part of an all employee share-saving
scheme, the following transactions were undertaken by Directors of the Company
on 6 May 2011:
Dr A W Nelson acquired 1,610 Ordinary Shares transferred from the IQE General
Employee Benefit Trust at a price of 107.3 pence per Ordinary Share. Following
this transaction, Dr Nelson's total beneficial interest in the Company has
increased to 27,482,913 Ordinary Shares representing 5.25% of the issued share
capital of the Company.
Dr H R Williams acquired 1,342 Ordinary Shares transferred from the IQE General
Employee Benefit Trust at a price of 107.3 pence per Ordinary Share. Following
this transaction, Dr Williams' total beneficial interest in the Company has
increased to 678,342 Ordinary Shares representing 0.12% of the issued share
capital of the Company.
Following the exercise of options by employees of IQE, the total number of
Ordinary Shares in issue as at 6 May 2011 is 522,902,846. All of these Ordinary
Shares carry voting rights of one vote per share. There are no Ordinary Shares
held in treasury and so the total number of voting rights in the Company is
currently 522,902,846.
The above figures may be used by shareholders as the denominator for the
calculations by which they will determine if they are required to notify their
interest in, or a change to their interest in, the Company under the Financial
Service Authority's Disclosure and Transparency Rules.
The Ordinary Shares referred to above are the ordinary shares of 1 pence each in
the Company.
Contacts:
IQE plc (+44 29 2083 9400)
Chris Meadows
Phil Rasmussen
Espirito Santo Investment Bank (+ 44 20 7456 9191)
Richard Crawley
James Bromhead
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: IQE plc via Thomson Reuters ONE
[HUG#1513355]
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.